Skip to main content

CORRECTION article

Front. Cardiovasc. Med. , 24 February 2025

Sec. Cardiac Rhythmology

Volume 12 - 2025 | https://doi.org/10.3389/fcvm.2025.1568459

Corrigendum: Divergent electrophysiologic action of dapagliflozin and empagliflozin on ventricular and atrial tachyarrhythmias in isolated rabbit hearts

\r\nJulian Wolfes
Julian Wolfes*Jan UphoffJan UphoffSven KemenaSven KemenaFelix WegnerFelix WegnerBenjamin RathBenjamin RathLars EckardtLars EckardtGerrit Frommeyer&#x;Gerrit FrommeyerChristian Ellermann&#x;\r\nChristian Ellermann
  • Department of Cardiology II, Electrophysiology, University Hospital Münster, Münster, Germany

A Corrigendum on

Divergent electrophysiologic action of dapagliflozin and empagliflozin on ventricular and atrial tachyarrhythmias in isolated rabbit hearts

Wolfes J, Uphoff J, Kemena S, Wegner F, Rath B, Eckardt L, Frommeyer G and Ellermann C (2024). Front. Cardiovasc. Med. 11:1369250. doi: 10.3389/fcvm.2024.1369250

In the published article, there was an error in the Funding statement. The author(s) stated that no financial support was received, however the research was funded by Hans und Gertie Fischer-Stiftung, Germany. The correct Funding statement appears below.

Funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This research was funded by Hans und Gertie Fischer -Stiftung.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: SGLT2, dapagliflozin, empagliflozin, langendorff, atrial fibrillation, short QT syndrome, long QT syndrome, arrhythmia

Citation: Wolfes J, Uphoff J, Kemena S, Wegner F, Rath B, Eckardt L, Frommeyer G and Ellermann C (2025) Corrigendum: Divergent electrophysiologic action of dapagliflozin and empagliflozin on ventricular and atrial tachyarrhythmias in isolated rabbit hearts. Front. Cardiovasc. Med. 12:1568459. doi: 10.3389/fcvm.2025.1568459

Received: 29 January 2025; Accepted: 4 February 2025;
Published: 24 February 2025.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright: © 2025 Wolfes, Uphoff, Kemena, Wegner, Rath, Eckardt, Frommeyer and Ellermann. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Julian Wolfes, anVsaWFuLndvbGZlc0B1a211ZW5zdGVyLmRl

These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

Man ultramarathon runner in the mountains he trains at sunset

95% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more